[1]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,(05):35-37,41.[doi:10.3969/j.issn.1006-1959.2018.05.014]
 JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Medical Information,2018,(05):35-37,41.[doi:10.3969/j.issn.1006-1959.2018.05.014]
点击复制

代谢综合征与肿瘤关系的研究进展()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期数:
2018年05期
页码:
35-37,41
栏目:
综述
出版日期:
2018-03-01

文章信息/Info

Title:
Research Progress on the Relationship between Metabolic Syndrome and Tumor
文章编号:
1006-1959(2018)05-0035-04
作者:
靳雪芹12邓正聪2
1.江汉大学,湖北 武汉 430056;2.武汉市九峰街社区卫生服务中心,湖北 武汉 430075
Author(s):
JIN Xue-qin12DENG Zheng-cong2
1.Jianghan University,Wuhan 430056S2,Hubei,China;2.Wuhan Jiufeng Street Community Health Service Center,Wuhan 430075,Hubei,China
关键词:
代谢综合征肿瘤2型糖尿病高血压
Keywords:
Key words:Metabolic syndromeTumorType 2 diabetes mellitusHypertension
分类号:
R736
DOI:
10.3969/j.issn.1006-1959.2018.05.014
文献标志码:
A
摘要:
随着经济水平的提高及生活方式的改变,我国代谢综合征的发病人数也在以惊人的速度增长,其与癌症的关系也引起广泛重视。MS增加癌症风险的潜在因素包括腹型肥胖、血脂紊乱、2型糖尿病、高血压、炎症、缺氧。研究表明MS及其相关组分在肿瘤的病因、进展及预后中发挥重要作用。本文就代谢综合征与肿瘤的研究进展做一综述。
Abstract:
Abstract:With the improvement of economic level and the change of lifestyle,the incidence of metabolic syndrome in China is increasing at an alarming rate,and its relationship with cancer has also attracted wide attention.The potential factors for increasing the risk of cancer in MS include abdominal obesity,dyslipidemia,type 2 diabetes,hypertension,inflammation,and hypoxia.The study shows that MS and its related components play an important role in the etiology,progression and prognosis of tumor.In this paper,the research progress of metabolic syndrome and tumor is reviewed.

参考文献/References:

[1]Siegel R,Ma J,Zou Z,et al.Cancer statistics,2014[J].Ca A Cancer Journal for Clinicians,2014,64(1):9. [2]Chen W,Zheng R,Zeng H,et al.Annual report on status of cancer in China,2011[J].Chin J Cancer Res,2015,27(1):2. [3]Cespedes Feliciano E M,Kwan M L,Kushi L H,et al.Body mass index,PAM50 subtype,recurrence and survival among patients with nonmetastatic breast cancer[J].Cancer,2017,123(13):2535-2542. [4]Berrino F,Villarini A,Traina A,et al.Metabolic syndrome and breast cancer prognosis[J].Breast Cancer Research&Treatment,2014,147(1):159-165. [5]Wu AH,Vigen C,Butler LM,et al.Metabolic conditions and breast cancer risk among Los Angeles County Filipina Americans compared with Chinese and Japanese Americans[J].International Journal of Cancer,2017,141(12):2450-2461. [6]Braakhuis A,Campion P,Bishop K.The Effects of Dietary Nutrition Education on Weight and Health Biomarkers in Breast Cancer Survivors[J].Medical Sciences,2017,5(2):12. [7]田垚,王毅,朱科云,等.代谢综合征与三阴性乳腺癌关系的研究进展[J].天津医药,2014,42(9):953-956.8]Ohashi R,Sangen M,Namimatsu S,et al.Prognostic value of IMP3 expression as a determinant of chemosensitivity in triple-negative breast cancer[J].Pathology-Research and Practice, 2017,213(9):1160-1165. [9]Krasimira A,Katharina N,Tobias P.Influence of Obesity and Related Metabolic Alterations on Colorectal Cancer Risk[J]. Current Nutrition Reports,2013,2(1):1-9. [10]Ulaganathan V,Kandiah M,Zalilah M S,et al.Colorectal cancer and its association with the metabolic syndrome:a Malaysian multi-centric case-control study[J].Asian Pac J Cancer Prev, 2012,13(8):3873-3877. [11]Chen Y,Wu F,Saito E,et al.Association between type 2 diabetes and risk of cancer mortality:a pooled analysis of over 771,000 individuals in the Asia Cohort Consortium[J].Diabetologia,2017,60(6):1-11. [12]Jia Y,Xu G,Zhou W,et al.Diabetes promotes DMH-induced colorectal cancer by increasing the activity of glycolytic enzymes in rats[J].Plos One,2014,9(10):e110455. [13]冯燕.代谢综合征合并结直肠癌脂肪组织IGF-I、ERK、GLUT4、IRS-1mRNA表达变化及意义[D].青岛大学,2012. [14]Chang LC,Wu MS,Tu CH,et al.Metabolic syndrome and smoking may justify earlier colorectal cancer screening in men[J].Gastrointestinal Endoscopy,2014,79(6):961-969. [15]Mantovani A,Targher G.Type 2 diabetes mellitus and risk of hepatocellular carcinoma:spotlight on nonalcoholic fatty liver disease[J].Annals of translational medicine,2017,5(13):270. [16]Wang CS,Yao WJ,Chang TT,et al.The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses[J].Cancer epidemiology,biomarkers &prevention:a publication of the American Association for Cancer Research,cosponsored by the American Society of Preventive Oncology,2009,18(7):2054. [17]严爱婷.胰腺癌继发性糖尿病的临床分析[J].医学信息,2015,28(14):311. [18]Dugnani E,Balzano G,Pasquale V,et al.Insulin resistance is associated with the aggressiveness of pancreatic ductal carcinoma[J].Acta Diabetologica,2016,53(6):945-956. [19]邢庆菲,郭战军,李常颖,等.代谢综合征与膀胱癌分级和分期相关性的研究[J].中华泌尿外科杂志,2015,36(10):761-764. [20]Ozbek E,Otunctemur A,Dursun M,et al.Association between the Metabolic Syndrome and High Tumor Grade and Stage of Primary Urothelial Cell Carcinoma of the Bladder[J].Asian Pacific Journal of Cancer Prevention Apjcp,2014,15(3):1447-1451. [21]Sha N,Xu H,Chen T,et al.The evaluation of the association between the metabolic syndrome and tumor grade and stage of bladder cancer in a Chinese population[J].Oncotargets&Therapy, 2016,9(Issue 1):1175. [22]吕建敏,李霖,刘溪,等.代谢综合征与肾癌恶性程度相关性研究[J].临床泌尿外科杂志,2016,30(12):1088-1091.

相似文献/References:

[1]杨森果,毛大华,杨海松,等.E-cadherin与肿瘤侵袭、转移相关性研究进展[J].医学信息,2018,(03):3.[doi:10.3969/j.issn.1006-1959.2018.04.002]
 YANG Sen-guo,MAO Da-hua,YANG Hai-song,et al.Research Progress of the Correlation between E-cadherin and Tumor Invasion and Metastasis[J].Medical Information,2018,(05):3.[doi:10.3969/j.issn.1006-1959.2018.04.002]
[2]江立基,李先明.碳酸酐酶Ⅸ在肿瘤中的研究进展[J].医学信息,2018,(03):7.[doi:10.3969/j.issn.1006-1959.2018.03.003]
 JIANG Li-ji,LI Xian-ming.Research Progress of Carbonic Anhydrase IX in Cancer[J].Medical Information,2018,(05):7.[doi:10.3969/j.issn.1006-1959.2018.03.003]
[3]龙 颖,李运泽,汤中敏,等.非酒精性脂肪性肝病与血尿酸水平测定及其临床意义[J].医学信息,2018,(07):92.[doi:10.3969/j.issn.1006-1959.2018.07.029]
 LONG Ying,LI Yun-ze,TANG Zhong-min,et al.Determination of Serum Uric Acid Level and its Clinical Significance in Non-alcoholic Fatty Liver Disease[J].Medical Information,2018,(05):92.[doi:10.3969/j.issn.1006-1959.2018.07.029]
[4]白 雪,邓 琦.血液系统肿瘤的细胞治疗研究进展[J].医学信息,2018,(10):41.[doi:10.3969/j.issn.1006-1959.2018.10.013]
 BAI Xue,DENG Qi.Advances in Cell Therapy for Blood System Tumor[J].Medical Information,2018,(05):41.[doi:10.3969/j.issn.1006-1959.2018.10.013]
[5]吕 宁,徐 昕,黄 永,等.公安民警皮肤软纤维瘤与代谢综合征危险因素相关性研究[J].医学信息,2018,(10):69.[doi:10.3969/j.issn.1006-1959.2018.10.021]
 LV Ning,XU Xin,HUANG Yong,et al.Correlative Study on Skin Soft Fibroma and Risk Factors of Metabolic Syndrome in Public Security Police[J].Medical Information,2018,(05):69.[doi:10.3969/j.issn.1006-1959.2018.10.021]
[6]王 静,刘 梅,焦菊凤.知-信-行健康教育模式对PICC置管肿瘤 患者自我护理能力的影响[J].医学信息,2018,(11):170.[doi:10.3969/j.issn.1006-1959.2018.11.056]
 WANG Jing,LIU Mei,JIAO Ju-feng.Effect of Knowledge-belief-behavioral Health Education Model on the Self-care Ability of Patients with Cancer in PICC Catheterization[J].Medical Information,2018,(05):170.[doi:10.3969/j.issn.1006-1959.2018.11.056]
[7]史红娟,李群锋,赵 华,等.舒林酸抗肿瘤作用的研究进展[J].医学信息,2018,(12):35.[doi:10.3969/j.issn.1006-1959.2018.12.012]
 SHI Hong-juan,LI Qun-feng,ZHAO Hua,et al.Advances in Research on Anti-tumor Effect of Sulindac[J].Medical Information,2018,(05):35.[doi:10.3969/j.issn.1006-1959.2018.12.012]
[8]郑文灿,法艳梅,吕亚青,等.苦参碱抗肿瘤机制的分子生物学研究进展[J].医学信息,2018,(19):51.[doi:10.3969/j.issn.1006-1959.2018.19.017]
 ZHENG Wen-can,FA Yan-mei,LV Ya-qing,et al.Advances in Molecular Biology of Matrine Antitumor Mechanism[J].Medical Information,2018,(05):51.[doi:10.3969/j.issn.1006-1959.2018.19.017]
[9]缪继东.盐酸吗啡缓释片联合低剂量阿米替林治疗中重度癌性骨痛的疗效观察[J].医学信息,2018,(21):147.[doi:10.3969/j.issn.1006-1959.2018.21.042]
 MIAO Ji-dong.Effects of Morphine Hydrochloride Sustained-release Tablets Combined with Low Dose Amitriptyline in the Treatment of Moderate and Severe Cancer Bone Pain[J].Medical Information,2018,(05):147.[doi:10.3969/j.issn.1006-1959.2018.21.042]
[10]庞小坤,韩 梅,江心灿,等.当归补血汤治疗肿瘤化疗不良反应随机对照临床试验的Meta分析[J].医学信息,2019,(02):69.[doi:10.3969/j.issn.1006-1959.2019.02.021]
 Pang Xiao-kun,Han Mei,Jiang Xin-can,et al.Meta-analysis of a Randomized Controlled Clinical Trial of Angelica Buxue Decoction in the Treatment of Adverse Reactions to Chemotherapy[J].Medical Information,2019,(05):69.[doi:10.3969/j.issn.1006-1959.2019.02.021]

更新日期/Last Update: 2018-03-01